Sangui Latino America

Sangui Latino America was a regional entity established in 2006 through a cooperation between the German biotech firm SanguiBioTech GmbH and the Mexican company ERC Nano Med S.A. de C.V. Based in Monterrey, Mexico, the company was founded to serve as the carrier for the "Clinica Sangui" initiative, focusing on the application of Sangui's proprietary hemoglobin-based technologies for wound healing. Its primary business involved the distribution and clinical application of Granulox, a hemoglobin-based wound spray designed to treat chronic hypoxia in wounds. While the entity was active in the mid-2000s, subsequent distribution rights for Sangui's products in Mexico were transitioned to other partners such as Bio-Mac Pharma and Laboratorios Silanes, and the company is no longer considered active.